Genomics
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Unlock global pharma market insights with cutting-edge genomics news. Drive R&D, investment, and regulatory strategy with data-driven intelligence.
Showing 1–3 of 3 articles
Quick answer
NovaPharmaNews Genomics hub for NMPA covers 3 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Illumina's APAC Strategy Under Nilesh Shah: A Competitive Benchmark
MyOme Appoints Two Healthcare Leaders to Board as AI Genomics Platform Expands
ACT Genomics Expands Cancer Genomic Testing Panel to 101 Genes with 7-Day Turnaround Time
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.